DNA repair targeted therapy: The past or future of cancer treatment?

Navnath S. Gavande, Pamela S. VanderVere-Carozza, Hilary D. Hinshaw, Shadia Jalal, Catherine Sears, Katherine S. Pawelczak, John Turchi

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

The repair of DNA damage is a complex process that relies on particular pathways to remedy specific types of damage to DNA. The range of insults to DNA includes small, modest changes in structure including mismatched bases and simple methylation events to oxidized bases, intra- and interstrand DNA crosslinks, DNA double strand breaks and protein-DNA adducts. Pathways required for the repair of these lesions include mismatch repair, base excision repair, nucleotide excision repair, and the homology directed repair/Fanconi anemia pathway. Each of these pathways contributes to genetic stability, and mutations in genes encoding proteins involved in these pathways have been demonstrated to promote genetic instability and cancer. In fact, it has been suggested that all cancers display defects in DNA repair. It has also been demonstrated that the ability of cancer cells to repair therapeutically induced DNA damage impacts therapeutic efficacy. This has led to targeting DNA repair pathways and proteins to develop anti-cancer agents that will increase sensitivity to traditional chemotherapeutics. While initial studies languished and were plagued by a lack of specificity and a defined mechanism of action, more recent approaches to exploit synthetic lethal interaction and develop high affinity chemical inhibitors have proven considerably more effective. In this review we will highlight recent advances and discuss previous failures in targeting DNA repair to pave the way for future DNA repair targeted agents and their use in cancer therapy.

Original languageEnglish (US)
JournalPharmacology and Therapeutics
DOIs
StateAccepted/In press - 2016

Fingerprint

DNA Repair
DNA Damage
Neoplasms
Therapeutics
Fanconi Anemia
Proteins
DNA Mismatch Repair
Double-Stranded DNA Breaks
DNA Adducts
DNA
Methylation
Mutation

Keywords

  • Cancer
  • DNA damage
  • DNA repair
  • Radiation
  • Replication protein A

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

DNA repair targeted therapy : The past or future of cancer treatment? / Gavande, Navnath S.; VanderVere-Carozza, Pamela S.; Hinshaw, Hilary D.; Jalal, Shadia; Sears, Catherine; Pawelczak, Katherine S.; Turchi, John.

In: Pharmacology and Therapeutics, 2016.

Research output: Contribution to journalArticle

Gavande, Navnath S. ; VanderVere-Carozza, Pamela S. ; Hinshaw, Hilary D. ; Jalal, Shadia ; Sears, Catherine ; Pawelczak, Katherine S. ; Turchi, John. / DNA repair targeted therapy : The past or future of cancer treatment?. In: Pharmacology and Therapeutics. 2016.
@article{d02c03c9b8c5470390d89afe5d6da3d8,
title = "DNA repair targeted therapy: The past or future of cancer treatment?",
abstract = "The repair of DNA damage is a complex process that relies on particular pathways to remedy specific types of damage to DNA. The range of insults to DNA includes small, modest changes in structure including mismatched bases and simple methylation events to oxidized bases, intra- and interstrand DNA crosslinks, DNA double strand breaks and protein-DNA adducts. Pathways required for the repair of these lesions include mismatch repair, base excision repair, nucleotide excision repair, and the homology directed repair/Fanconi anemia pathway. Each of these pathways contributes to genetic stability, and mutations in genes encoding proteins involved in these pathways have been demonstrated to promote genetic instability and cancer. In fact, it has been suggested that all cancers display defects in DNA repair. It has also been demonstrated that the ability of cancer cells to repair therapeutically induced DNA damage impacts therapeutic efficacy. This has led to targeting DNA repair pathways and proteins to develop anti-cancer agents that will increase sensitivity to traditional chemotherapeutics. While initial studies languished and were plagued by a lack of specificity and a defined mechanism of action, more recent approaches to exploit synthetic lethal interaction and develop high affinity chemical inhibitors have proven considerably more effective. In this review we will highlight recent advances and discuss previous failures in targeting DNA repair to pave the way for future DNA repair targeted agents and their use in cancer therapy.",
keywords = "Cancer, DNA damage, DNA repair, Radiation, Replication protein A",
author = "Gavande, {Navnath S.} and VanderVere-Carozza, {Pamela S.} and Hinshaw, {Hilary D.} and Shadia Jalal and Catherine Sears and Pawelczak, {Katherine S.} and John Turchi",
year = "2016",
doi = "10.1016/j.pharmthera.2016.02.003",
language = "English (US)",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - DNA repair targeted therapy

T2 - The past or future of cancer treatment?

AU - Gavande, Navnath S.

AU - VanderVere-Carozza, Pamela S.

AU - Hinshaw, Hilary D.

AU - Jalal, Shadia

AU - Sears, Catherine

AU - Pawelczak, Katherine S.

AU - Turchi, John

PY - 2016

Y1 - 2016

N2 - The repair of DNA damage is a complex process that relies on particular pathways to remedy specific types of damage to DNA. The range of insults to DNA includes small, modest changes in structure including mismatched bases and simple methylation events to oxidized bases, intra- and interstrand DNA crosslinks, DNA double strand breaks and protein-DNA adducts. Pathways required for the repair of these lesions include mismatch repair, base excision repair, nucleotide excision repair, and the homology directed repair/Fanconi anemia pathway. Each of these pathways contributes to genetic stability, and mutations in genes encoding proteins involved in these pathways have been demonstrated to promote genetic instability and cancer. In fact, it has been suggested that all cancers display defects in DNA repair. It has also been demonstrated that the ability of cancer cells to repair therapeutically induced DNA damage impacts therapeutic efficacy. This has led to targeting DNA repair pathways and proteins to develop anti-cancer agents that will increase sensitivity to traditional chemotherapeutics. While initial studies languished and were plagued by a lack of specificity and a defined mechanism of action, more recent approaches to exploit synthetic lethal interaction and develop high affinity chemical inhibitors have proven considerably more effective. In this review we will highlight recent advances and discuss previous failures in targeting DNA repair to pave the way for future DNA repair targeted agents and their use in cancer therapy.

AB - The repair of DNA damage is a complex process that relies on particular pathways to remedy specific types of damage to DNA. The range of insults to DNA includes small, modest changes in structure including mismatched bases and simple methylation events to oxidized bases, intra- and interstrand DNA crosslinks, DNA double strand breaks and protein-DNA adducts. Pathways required for the repair of these lesions include mismatch repair, base excision repair, nucleotide excision repair, and the homology directed repair/Fanconi anemia pathway. Each of these pathways contributes to genetic stability, and mutations in genes encoding proteins involved in these pathways have been demonstrated to promote genetic instability and cancer. In fact, it has been suggested that all cancers display defects in DNA repair. It has also been demonstrated that the ability of cancer cells to repair therapeutically induced DNA damage impacts therapeutic efficacy. This has led to targeting DNA repair pathways and proteins to develop anti-cancer agents that will increase sensitivity to traditional chemotherapeutics. While initial studies languished and were plagued by a lack of specificity and a defined mechanism of action, more recent approaches to exploit synthetic lethal interaction and develop high affinity chemical inhibitors have proven considerably more effective. In this review we will highlight recent advances and discuss previous failures in targeting DNA repair to pave the way for future DNA repair targeted agents and their use in cancer therapy.

KW - Cancer

KW - DNA damage

KW - DNA repair

KW - Radiation

KW - Replication protein A

UR - http://www.scopus.com/inward/record.url?scp=84959561469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959561469&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2016.02.003

DO - 10.1016/j.pharmthera.2016.02.003

M3 - Article

C2 - 26896565

AN - SCOPUS:84959561469

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

ER -